Diabetes Tablet Franchise in Ahmedabad

Name: Istalab 25 Tablet (Sitagliptin 25 mg Tablet)
Brand: Istalab 25 Tablet
Rating: 4.8 (150 reviews)

Anti Diabetic Medicine Supplier in Mumbai

Diabetes Medicine Distributor in Delhi

Sitagliptin Tablet Manufacturer in Bangalore

Diabetic Tablet Stockist in Hyderabad

Diabetes Tablet Exporter in Chandigarh

Home/Products /sitagliptin-25mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Sitagliptin 25 mg Tablet Exporter in Gujarat

Sitagliptin 25 mg Tablet by top PCD Pharma

Sitagliptin 25 mg Tablet – PCD Pharma Franchise Marketing Material

Istalab 25 Tablet

Composition : Sitagliptin (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 1x7

Price : ₹1/-

Contact For Business Query

Istalab 25 Tablet containing Sitagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.

Sitagliptin works as a DPP-4 inhibitor, which increases insulin release after meals and reduces glucose production, helping maintain stable blood sugar levels.

The tablet is widely prescribed in diabetic care for long-term management, often used as part of combination therapy, leading to consistent demand and repeat usage.

With increasing prevalence of diabetes and growing awareness of glucose control management, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and wide acceptance in endocrinology practice make it a reliable product for consistent sales and growth in the anti-diabetic segment.

About the Product

Istalab 25 Tablet containing Sitagliptin is used for the management of type 2 diabetes mellitus. It helps in controlling blood sugar levels and improving overall glycemic control.

Sitagliptin works as a DPP-4 inhibitor, which increases insulin release after meals and reduces glucose production, helping maintain stable blood sugar levels.

The tablet is widely prescribed in diabetic care for long-term management, often used as part of combination therapy, leading to consistent demand and repeat usage.

Some patients may experience headache, upper respiratory tract infections, nasal congestion, nausea, or mild gastrointestinal discomfort. Rarely, pancreatitis, joint pain, or severe allergic reactions may occur and require medical attention.

Istalab 25 Tablet is indicated for the management of type 2 diabetes mellitus, either alone or in combination with other antidiabetic agents. It helps reduce fasting and postprandial blood glucose levels, improve insulin response, and support long-term glycemic control.

This medicine should be used under medical supervision along with diet and exercise control. Regular monitoring of blood glucose levels is recommended. Patients with pancreatic or kidney issues should use it cautiously.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.